CXCR4 is a critical receptor to modulate tumor-stromal interactions including cell invasion and migration, and therapeutic resistance (44), and blocking of CXCR4 by AMD3100 increases the anti-tumor effect of docetaxel in PCa patients with tumor metastasis (45). Here, CXCR4 is linked to neoplasm.